BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3627825)

  • 1. Isolation and characterization of a monoclonal anti-P30 antibody resistant mutant of Toxoplasma gondii.
    Kasper LH
    Parasite Immunol; 1987 Jul; 9(4):433-45. PubMed ID: 3627825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and characterization of a monoclonal antibody-resistant antigenic mutant of Toxoplasma gondii.
    Kasper LH; Crabb JH; Pfefferkorn ER
    J Immunol; 1982 Oct; 129(4):1694-9. PubMed ID: 7108224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to Toxoplasma gondii major surface protein (SAG-1, P30) inhibit infection of host cells and are produced in murine intestine after peroral infection.
    Mineo JR; McLeod R; Mack D; Smith J; Khan IA; Ely KH; Kasper LH
    J Immunol; 1993 May; 150(9):3951-64. PubMed ID: 7682587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major surface protein of Toxoplasma gondii (p30) contains an immunodominant region with repetitive epitopes.
    Rodriguez C; Afchain D; Capron A; Dissous C; Santoro F
    Eur J Immunol; 1985 Jul; 15(7):747-9. PubMed ID: 2408905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of a major membrane protein of Toxoplasma gondii by immunoabsorption with a monoclonal antibody.
    Kasper LH; Crabb JH; Pfefferkorn ER
    J Immunol; 1983 May; 130(5):2407-12. PubMed ID: 6833761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxoplasma gondii: redistribution of monoclonal antibodies on tachyzoites during host cell invasion.
    Dubremetz JF; Rodriguez C; Ferreira E
    Exp Parasitol; 1985 Feb; 59(1):24-32. PubMed ID: 3881269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of stage-specific sporozoite antigens of Toxoplasma gondii by monoclonal antibodies.
    Kasper LH; Bradley MS; Pfefferkorn ER
    J Immunol; 1984 Jan; 132(1):443-9. PubMed ID: 6197455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An unexpected response to vaccination with a purified major membrane tachyzoite antigen (P30) of Toxoplasma gondii.
    Kasper LH; Currie KM; Bradley MS
    J Immunol; 1985 May; 134(5):3426-31. PubMed ID: 3884710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a monoclonal antibody in a double-sandwich ELISA for detection of IgM antibodies to Toxoplasma gondii major surface protein (P30).
    Cesbron JY; Capron A; Ovlaque G; Santoro F
    J Immunol Methods; 1985 Oct; 83(1):151-8. PubMed ID: 4056400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic similarity between Hammondia hammondi and Toxoplasma gondii tachyzoites.
    Riahi H; Bouteille B; Darde ML
    J Parasitol; 1998 Jun; 84(3):651-3. PubMed ID: 9645881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attachment of Toxoplasma gondii to host cells involves major surface protein, SAG-1 (P30).
    Mineo JR; Kasper LH
    Exp Parasitol; 1994 Aug; 79(1):11-20. PubMed ID: 8050521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Toxoplasma gondii: the characterization of an anti-P30 monoclonal antibody].
    Fachado A; Fernández N; Hernández E; Fonseca L
    Rev Cubana Med Trop; 1996; 48(3):178-83. PubMed ID: 9805047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunodominant epitope of the major membrane tachyzoite protein (P30) of Toxoplasma gondii.
    Santoro F; Charif H; Capron A
    Parasite Immunol; 1986 Nov; 8(6):631-9. PubMed ID: 2433673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of antigen-specific parasiticidal cytotoxic T cell splenocytes by a major membrane protein (P30) of Toxoplasma gondii.
    Khan IA; Smith KA; Kasper LH
    J Immunol; 1988 Nov; 141(10):3600-5. PubMed ID: 2460541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of specific antibodies to Toxoplasma gondii by a competitive enzyme immunoassay using a monoclonal antibody against the P30 antigen.
    Fortier B; Rolland D; Ajana F; Dubremetz JF; Vernes A
    Eur J Clin Microbiol Infect Dis; 1991 Jan; 10(1):38-40. PubMed ID: 2009877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression, purification and serological reactivity of a chimeric antigen of GRA6 with P30 from Toxoplasma gondii].
    Li YX; Zhang JH; Tao KH; Huang PT
    Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):674-9. PubMed ID: 15971578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serodiagnosis of toxoplasma infection using a purified parasite protein (P30).
    Santoro F; Afchain D; Pierce R; Cesbron JY; Ovlaque G; Capron A
    Clin Exp Immunol; 1985 Nov; 62(2):262-9. PubMed ID: 2417762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxoplasma gondii-structure variations of the antigen P30.
    Bonhomme A; Thirion C; Boulanger F; Charton F; Burlet H; Pinon JM; Alix AJ
    Parasitology; 1994 Apr; 108 ( Pt 3)():281-7. PubMed ID: 7517518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen-specific (p30) mouse CD8+ T cells are cytotoxic against Toxoplasma gondii-infected peritoneal macrophages.
    Kasper LH; Khan IA; Ely KH; Buelow R; Boothroyd JC
    J Immunol; 1992 Mar; 148(5):1493-8. PubMed ID: 1538132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxoplasmacidal activity of macrophages activated by recombinant major surface antigen (P30) of Toxoplasma gondii.
    Makioka A; Kobayashi A
    Infect Immun; 1991 Aug; 59(8):2851-2. PubMed ID: 1856000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.